APA (7th ed.) Citation

Wu, B., Liu, L., Lu, X., Hong, D., & Ma, K. Cost-effectiveness analysis of cinacalcet for haemodialysis patients with moderate-to-severe secondary hyperparathyroidism in China: Evaluation based on the EVOLVE trial. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Wu, Bin, Lin Liu, Xiaoyang Lu, Dongsheng Hong, and Kuifen Ma. Cost-effectiveness Analysis of Cinacalcet for Haemodialysis Patients with Moderate-to-severe Secondary Hyperparathyroidism in China: Evaluation Based on the EVOLVE Trial. BMJ Publishing Group.

MLA (9th ed.) Citation

Wu, Bin, et al. Cost-effectiveness Analysis of Cinacalcet for Haemodialysis Patients with Moderate-to-severe Secondary Hyperparathyroidism in China: Evaluation Based on the EVOLVE Trial. BMJ Publishing Group.